Assignment 3: International Crime Witness part 2
Write a three to five page paper in which you. 1. The country is Saudi Arabia Analyze both the court system likely view on the accused’s rights, as well. as the court system likely treatment of the defendant during trial proceedings. Provide support for the analysis. 2. Assuming the accused is ultimately sentenced to a term of imprisonment, depict the most likely experience the defendant will have within the country prison system. Provide justification for your view of the country prison system. 3. Expose two ethical concerns you witnessed regarding the countr court and correctional systems. 4. Provide one recommendation for change within each of the systems (courts and correctional). 5. Use at least four quality references. Must be typed double spaced, using times new roman font 12 with one inch margins on all sides: citations and references must follow APA format. Include a cover page containing the title of the assignment, the student name, the professor name, the course title, and the date. The cover page and the reference page are not included in the required assignment page length. I want original work not someone else work. My school uses safe assign so i will know if if the paper is someone else work. Cannot be no more than 20%.. I do not want want someone else work.
Order This Solution
49051 Millions developed by 10% and working benefit in 2009 was 15012 Millions that developed by 6%. Roche is contributed CHF. 9874 Millions on R&D in 2009. The free trade stream out 2009 was 8893 that was 79% more than 2008. The aggregate representative of Roche are 81507. Out of them 80115 are changeless. The Sales commitment is more from US that is 38% than West Europe that is 28%. Since pharmaceutical advertising exercises impact the endorsing conduct of specialists, it is of most extreme significance to basically dissect the cases made in the limited time material of the medications. The degree to which pharmaceutical organizations advance the benefits of their items and applicable clinical trails give to specialists are not examined in Pakistan. The consequences of the present logical examination demonstrate that untrustworthy and one-sided claims with respect to the pharmaceutical items are uncontrolled in Pakistan. These medication advancements impact the recommending conduct of the General Practitioners, Consultants in this manner representing one of the possibly significant reasons for outlandish solution. Roche Pakistan Ltd is a Member of IFPMA and PMA and take after their moral business rules to offer its items. Roche Paksitan Ltd is at sixth positioning in Pakistan Pharmaceutical Market and its yearly deal is Rs. 5.2 Billions out of 2009 in Pakistan.>GET ANSWER